A bird's-eye view of cell therapy and tissue engineering for cardiac regeneration

Annals of the New York Academy of Sciences

Volumn 1254, Issue 1, 2012, Pages 57-65

  Soler Botija, Carolina ^a   Bagó, Juli R ^b,c   Bayes Genis, Antoni ^a,b,d  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c Institut Català de Ciències Cardiovasculars   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cardiac ATDPCs; Cardiac regeneration; Noninvasive bioluminescence; Tissue engineering

Indexed keywords

ALPHA ACTIN; CONNEXIN 43; FIBRIN; FIBRIN GLUE; MYOSIN HEAVY CHAIN BETA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR GATA 4;

ADIPOSE DERIVED STEM CELL; ARTICLE; BIOLUMINESCENCE; CARDIAC REGENERATION; CELL SURVIVAL; CELL THERAPY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HYDROGEL; NONHUMAN; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION;

AVES; MURINAE;

EID: 84860432328     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06519.x     Document Type: Article

References (67)

1. Olivetti, G. et al 1991. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ. Res. 68: 856-869.
2. Orlic, D. et al 2001. Bone marrow cells regenerate infarcted myocardium. Nature. 410: 701-705.
3. Genovese, J. et al 2007. Cell based approaches for myocardial regeneration and artificial myocardium. Curr. Stem Cell Res. Ther. 2: 121-127.
4. Chachques, J.C. et al 2009. Cardiomyoplasty: is it still a viable option in patients with end-stage heart failure? Eur. J. Cardiothorac. Surg. 35: 201-203.
5. Bayes-Genis, A. et al 2010. Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. J. Mol. Cell Cardiol. 49: 771-780.
6. Beltrami, A.P. et al 2003. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776.
7. Oh, H. et al 2003. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U.S.A. 100: 12313-12318.
8. Laugwitz, K.L. et al 2005. Postnatal isl1? Cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647-653.
9. Smith, R.R. et al 2007. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115: 896-908.
10. Orlic, D, et al 2001. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. N.Y. Acad. Sci. 938: 221-229
11. Rangappa, S. et al 2003. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann. Thorac. Surg. 75: 775-779.
12. Behfar A, et al 2010. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J. Am. Coll. Cardiol. 56: 721-734.
13. Roura, S. et al 2010. Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells. Basic Res. Cardiol. 105: 419-430.
14. Vunjak-Novakovic, G. et al 2010. Challenges in cardiac tissue engineering. Tissue. Eng. Part B Rev. 16: 169-187.
15. Gimble, J.M., A.J. Katz & B.A. Bunnell 2007. Adipose-derived stem cells for regenerative medicine. Circ. Res. 100: 1249-1260.
16. Passier, R., L.W. van Laake & C.L. Mummery 2008. Stem-cell based therapy and lessons from the heart. Nature 453:322-329.
17. Miura, M. et al 2003. SHED: stem cells from human exfoliated deciduous teeth. Proc. Natl. Acad. Sci. U.S.A. 100: 5807-5812.
18. Gandia, C. et al 2008. Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells 26: 638-645.
19. Zhang, S. et al 2004. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 110: 3803-3807.
20. Pei, M., F. He & G. Vunjak-Novakovic 2008. Synovium derived stem cell-based chondrogenesis. Differentiation 76: 1044-1056.
21. Kehat, I. et al 2004. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22: 1282-1289.
22. Yang, L. et al 2008. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cellderived population. Nature 453: 524-528.
23. Caspi, O. et al 2007. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 100: 263-272.
24. Cao, F. et al 2007. Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev. 16: 883-891.
25. Takahashi, K. & S. Yamanaka 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
26. Takahashi, K. et al 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
27. Yu, J. et al 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
28. Woltjen, K. et al 2009. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766-770.
29. Ivics, Z. et al 2009. Transposon-mediated genome manipulation in vertebrates. Nat. Methods 6: 415-422.
30. Zhou, H. et al 2009. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384.
31. Assmus, B. et al 2006. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355: 1222-1232.
32. Janssens, S. et al 2006. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367: 113-121.
33. Lunde, K. et al 2006. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355: 1199-1209.
34. Schachinger, V. et al 2006. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355: 1210-1221.
35. Povsic, T.J. et al 2011. A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. Am. Heart J. 162: 654-662.
36. Amado, L.C. et al 2005. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 102: 11474-11479.
37. Shimizu, T. et al 2002. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res. 90: e40.
38. Masuda, S. et al 2008. Cell sheet engineering for heart tissue repair. Adv. Drug. Deliv. Rev. 60: 277-285.
39. Kofidis, T. et al 2004. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J. Thorac. Cardiovasc. Surg. 128: 571-578.
40. Christman, K.L. et al 2004. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 10: 403-409.
41. Tokunaga, M. et al 2010. Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction. J. Mol. Cell. Cardiol. 49: 972-983.
42. Li, R.K. et al 1999. Survival and function of bioengineered cardiac grafts. Circulation. 100: II63-II69.
43. Leor, J. et al 2000. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 102: III56-III61.
44. Vizzardi, E. et al 2012. Stem cells and repair of the heart: cell-releasing epicardial scaffolds. J. Cardiovasc. Surg. (Torino). Jan 17. [Epub ahead of print].
45. Radisic, M. et al 2005. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am. J. Physiol. Heart Circ. Physiol. 288: H1278-H1289.
46. Radisic, M. et al 2006. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng. 12: 2077-2091.
47. Cortes-Morichetti, M. et al 2007. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng. 13: 2681-2687.
48. Chiu, L.L. et al 2008. Biphasic electrical field stimulation AIDS in tissue engineering of multicell-type cardiac organoids. Tissue Eng. Part A 17: 1465-1477.
49. Tandon, N., et al 2009. Electrical stimulation systems for cardiac tissue engineering. Nat. Protoc. 4: 155-173.
50. Radisic, M. et al 2004. From the cover: functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. USA 101: 18129-18134.
51. Zimmermann, W.H. et al 2002. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 90: 223-230.
52. Ott, H.C. et al 2008. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 14: 213-221.
53. Chachques, J.C. et al 2004. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. J. Thorac. Cardiovasc. Surg. 128: 245-253.
54. Laflamme, M.A. et al 2007. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25: 1015-1024.
55. Ferreira, L.S. et al 2007. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 28: 2706-2717.
56. Ahima, R.S. & J.S. Flier 2000. Adipose tissue as an endocrine organ. Trends. Endocrinol. Metab. 11: 327-332.
57. Pezeshkian, M. et al 2009. Fatty acid composition of epicardial and subcutaneous human adipose tissue. Metab. Syndr. Relat. Disord. 7: 125-131.
58. Pittenger, M.F. et al 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
59. Zimmermann, W.H. et al 2000. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 68: 106-114.
60. Patel, A.N. & J.A. Genovese 2007. Stem cell therapy for the treatment of heart failure. Curr. Opin. Cardiol. 22: 464-470.
61. Chachques, J.C. et al 2008. A Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study. Ann. Thorac. Surg. 85: 901-908.
62. Godier-Furnémont, A.F. et al 2011. Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc. Natl. Acad. Sci. U.S.A. 108: 7974-7979.
63. Miyagawa, S. et al 2011. Tissue-engineered cardiac constructs for cardiac repair. Ann. Thorac. Surg. 91: 320-329.
64. Ahmed, T.A., E.V. Dare & M. Hincke 2008. Fibrin: a versatile scaffold for tissue engineering applications. Tissue. Eng. Part B Rev. 14: 199-215.
65. Leor, J., Y. Amsalem & S. Cohen 2005. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol. Ther. 105: 151-163.
66. Christman, K.L. et al 2004. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44: 654-660.
67. Vilalta, M. et al 2009. Dual luciferase labelling for non-invasive bioluminescence imaging of mesenchymal stromal cell chondrogenic differentiation in demineralized bone matrix scaffolds. Biomaterials 30: 4986-4995.